The company was founded on May 18, 1992. On April 26, 1993, the company was listed on the Shenzhen Stock Exchange with the approval of the National Sports Reform Commission Document No. 87 (1992) and Su Zhengfu (1992) Document No. 62 of the Jiangsu Provincial People's Government. The company is mainly engaged in biomedical products, production and sales, and landscaping engineering business. The company's main products include EPO injections, injectable interleukin-2, etc.
Clinical Trials
0
0 active
Approvals
4
Total approvals
Agencies
1
Regulatory bodies
Founded
1992
No trial phase data available
No trial data available
No trial data available
No news articles found
